LIGAND PHARMACEUTICALS INCORPORATED: operating_income
| Value | {"amount": 37500000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8fd3296f-ce28-4013-92d8-fa1c4a0f9129
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-23-000007Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/operating-income/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8fd3296f-ce28-4013-92d8-fa1c4a0f9129
History
- supersedes {"amount": 25845000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0000886163-21-000050)